Guidelines
The GOC Guidelines are statements that provide recommendations for the diagnosis, treatment, or prevention of gynecologic cancers based on the best available evidence and expert consensus.
Guidelines - A work in progress
The Gynecologic Oncology of Canada (GOC) is currently developing and
updating clinical guidelines to address key areas of practice in gynecologic oncology.
Lignes directrices canadiennes sur la colposcopie
Une approche de la prise en charge et de la surveillance de la dysplasie du col de l’utérus fondée sur le risque, 2023
Lignes directrices canadiennes sur la colposcopie
Une approche de la prise en charge et de la surveillance de la dysplasie du col de l’utérus fondée sur le risque, 2023
Current Oncology | Free Full-Text
Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations (mdpi.com)
Lignes directrices canadiennes
Sur la prise en charge des personnes ayant obtenu un résultat positif au test de détection des virus du papillome humain et orientations pour certaines populations
Current Oncology | PDF Download
HPV Testing, Self-Collection, and Vaccination: A Comprehensive Approach to Cervical Cancer Prevention
GI/Hepatic - irAEs
Key principles of hepatic and GI immune-related adverse events
Rheumatologic Immune - irAEs
Key principles of rheumatologic immune-related adverse events (irAEs)
Endocrine - irAEs
Principles of endocrine immune-related adverse events (irAEs) caused by immune checkpoint inhibitors (ICIs)
Dermatology - irAEs
Managing Skin Toxicities Related to Immune Checkpoint Inhibitor Therapy
Upcoming Events
2026
- CPD - Toronto, Ont April 23 & 24
- AGM - Ottawa, Ont June 19-20
Toolkit
Molecular Diagnostic Toolkit Endometrial & Vulvar Cancer
Guide
Ovarian cancer occurs from the growth of cancer cells that form in the ovaries.
Current CoPs
If you are interested in joining a CoP please email enquiry@gyneoncology.ca
To focus on Enhanced Recovery After Surgery (ERAS). To provide updated recommendations about prophylaxis and treatment of venous thromboembolism (VTE) in patients with gynecologic malignancies in order to reduce the risk of morbidity and mortality in our patient population.
Facilitate the coordination and alignment of endeavors involving diverse healthcare professionals dedicated to diagnosis, treatment, and prevention of BRCA-related malignancies.
To create standardized treatment guidelines and national patient registries and biobanking, in an effort to advance knowledge
Newly being developed
Develop evidence-based recommendations, standards and knowledge translation initiatives on topics that impact daily practice of Gynecologic Oncology; Maintain a multi-institution database to enable shared research projects and QI initiatives;
Facilitate collaborations between centres that are members of NOIP; Support OI education and teaching for fellows and residents with a focus on GYN Oncology.
To provide a dynamic and iterative platform for all those who have an interest in HPV, HPV-related cancers and particularly in cervical cancer.
To identify priorities for GTN Care in Canada. To develop care pathways, a network, a national database and patient information tools.
Position Statements
Our position statements express the opinions of GOC on a variety of topics or issues related to gynecologic oncology. They are all based on evidence, research, and expert consensus, and they aim to provide guidance, recommendations, and gynecologic oncology standards.
CA 125 Monitoring in the Management of Recurrent Ovarian Cancer
Results of a multi-institutional European trial comparing early treatment of relapsed ovarian cancer based on CA125 only versus delayed treatment based on conventional clinical indicators after completion of first line chemotherapy, was presented at the American Society of Clinical Oncology meeting (ASCO) on May 31st.
French 
English